Peyton Greenside is CEO and co-founder of BigHat Biosciences, where she leads the development of AI- and synthetic-biology-enabled platforms for designing next-generation antibody therapeutics. She is a computational biologist and former Schmidt Science Fellow, with research and industry experience spanning biological sequence modeling, machine learning, and protein engineering.
Peyton Greenside is CEO and co-founder of BigHat Biosciences, where she leads the development of AI- and synthetic-biology-enabled platforms for designing next-generation antibody therapeutics. She is a computational biologist and former Schmidt Science Fellow, with research and industry experience spanning biological sequence modeling, machine learning, and protein engineering.
Career
Peyton Greenside studied at Stanford University (PhD), University of Cambridge (MPhil in Computational Biology), and Harvard University (BA in Applied Mathematics).
CEO at BigHat Biosciences until Present